- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, December 14, 2018
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A study published in The American Journal of Managed Care® (AJMC®) was mentioned in an article from Health Leaders Media. The study, “High-Touch Care Leads to Better Outcomes and Lower Costs in a Senior Population,” evaluated the impact of a high-touch primary care model among a Medicare Advantage population in comparison with a standard practice—based model. Researchers concluded that those receiving high-touch care had lower healthcare costs and fewer hospitalizations.
OBR Oncology’s Tuesday daily newsfeed included 3 articles from AJMC®. The first article, “Value of Breast Cancer Tests Highlighted in San Antonio,” covered data being presented at the San Antonio Breast Cancer Symposium on competing tests that direct breast cancer treatment. The article “What Might Come After the Oncology Care Model” suggested that while the model is likely not a sustainable model for oncology care, it will probably inform what payment structure comes next. The third article, “More Than 300 Groups Seek Halt to CMS’ Plans for Global Drug Pricing Index,” covered the news that a large coalition of medical associations, patient advocacy groups, drug companies, and others sent a letter to Congress asking that they intervene in CMS’ plan for a global drug pricing index, saying it would negatively affect the elderly and people with disabilities.
The National Pharmaceutical Council’s Wednesday CER Daily Newsfeed included an AJMC® interview with Brian Koffman, MDCM, DCFP, DABFM, MS Ed, medical director, CLL Society. During the interview, Koffman explained how patient-reported outcomes can provide insight into chimeric antigen receptor T-cell therapy.
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
